Center for Cancer Immunology and Immunotherapy Admin Core (CCII)
Official title: Center for Cancer Immunology and Immunotherapy (CCII) - Admin Core
Funded at University of Louisville · NIH-11399779 · Data updated 2026-11-12
A center at the University of Louisville is coordinating research efforts to understand cancer immunology and develop new immunotherapies, with a focus on supporting investigators and pilot projects.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project start | February 1, 2020 |
| Project end | May 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $910,366 |
| NIH project number | 5P20GM135004-07 |
| Project ID | NIH-11399779 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with cancer who could benefit from advancing cancer immunotherapy research and who may participate indirectly through future trials or access to new treatments.
✕Less likely to help
Patients not currently eligible for specific trials or those not connected to immunotherapy research projects may not see direct benefits.
What this research studies
This grant funds the Administrative Core of a Cancer Immunology and Immunotherapy center, coordinating more than 30 researchers and staff. It provides oversight, budgeting, mentoring, and support for pilot projects, biostatistics, data science, and regulatory compliance. It also helps recruit junior investigators and fosters strategic planning and collaboration across project leaders, mentors, and advisory committee members. The goal is to strengthen a multidisciplinary program that may accelerate discovery and translation to improve cancer immunotherapy.
Why it matters
Potential benefit: If successful, patients could benefit from faster, more coordinated research leading to new immunotherapies.
How similar studies have gone: Previous COBRE centers have shown that strong administrative cores improve project success and collaboration, enabling translational progress.
Where this research is happening
-
University of Louisville
Louisville, United States Active
Researchers
- Principal investigator: Yan, Jun — University of Louisville
- Study coordinator: Yan, Jun
Related research
Other NIH-funded projects on the same topics.
-
Boosting immune response to fight cancer
This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.
-
A center focused on immunotherapy for pediatric cancers.
This study is exploring new ways to use the body's immune system to fight childhood cancers, aiming to create better treatments for kids whose cancers haven't responded well to standard therapies.
-
Algorithms to find HLA-E neoantigens for cancer immunotherapy
Aims to develop computer methods to discover tumor-specific targets presented by HLA-E to guide new T cell therapies for cancer.
-
Immunotherapy for glioblastoma: advancing treatment and understanding
A patient-friendly summary of a grant exploring new immune-based treatments for glioblastoma to improve options for people affected by this brain cancer.
-
How CRISPR-based gene activation could shape immunotherapy responses in clear cell cancers
A research project at Stanford is using CRISPR-based gene activation to understand why some clear cell ovarian and kidney cancers respond to immunotherapy while others do not.
-
Hybrid biomaterial system to boost immunotherapy for rheumatoid arthritis
A new, patient-facing immunotherapy approach uses specialized particles to retrain the immune system to calm RA in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.